Liu Y, Gu X, Li Y, et al. Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function. Nature medicine. 2025. doi:10.1038/s41591-025-03891-5
Infectious Disease and Microbiome Program, Infectious Disease and Microbiome
Park JD, Lee SR, Dhennezel C, et al. Elucidating the role of Campylobacter concisus-derived indole metabolites in gut inflammation and immune modulation. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(34):e2514071122. doi:10.1073/pnas.2514071122
Kreitz J, Yang V, Friedrich MJ, Pham J, Macrae RK, Zhang F. Targeted delivery of diverse biomolecules with engineered bacterial nanosyringes. Nature biotechnology. 2025. doi:10.1038/s41587-025-02774-x
LaVerriere E, Johnson ZM, Shieh M, et al. Marked heterogeneity in malaria infection rate in a Malian longitudinal cohort. Nature communications. 2025;16(1):6512. doi:10.1038/s41467-025-61462-1
Krishnan A. A generative deep learning approach to de novo antibiotic design. Cell. 2025. doi:10.1016/j.cell.2025.07.033
Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):598-605. doi:10.1038/nm.4102
Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med. 2016;22(6):586-97. doi:10.1038/nm.4106
David LA, Materna AC, Friedman J, et al. Erratum to: Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2016;17(1):117. doi:10.1186/s13059-016-0988-y
Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341-52. doi:10.1038/nri.2016.42
Pardee K, Green AA, Takahashi MK, et al. Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components. Cell. 2016;165(5):1255-66. doi:10.1016/j.cell.2016.04.059